IBSS BIOMED S.A. History

2018
Modernisation and launch of a new vaccine filling line
2016
Launch of a vaccine active substance production department after general renovation
2015
Establishment of a Research and Development Centre (R&DC)
2008
Creation of the Business Development Department
2003
Establishing the name Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna (Institute of Serum and Vaccine Biotechnology - Joint Stock Company)
2001
Transformation of the production facility into a joint stock company (Polish: Spółka Akcyjna)
1998
Transformation of the Serum and Vaccine Manufacturing Plant into a company wholly owned by the State Treasury
1980
Establishing a new independent unit of the Serum and Vaccine Manufactory BIOMED – Krakow.
1950
Extending the Manufactory’s base in Krakow with the private Serum and Vaccine Production Plant of prof. Odon Bujwid – an associate of Louis Pasteur.
1950
Plant reorganization and an foundation of the Serum and Vaccine Manufactory Unification “BIOMED,” having its seats in Krakow, Warszawa and Lublin.
Starting the vaccine production, among others: vaccine against the exanthematous fever, typhoid fever, pseudo-typhus and dysentery, so-called “Penty.”
Setting up a production team made of people who rendered great service to the Polish science: Tadeusz Korzybski, Jan Kostrzewski, Wlodzimierz Kurylowicz and Stefan Slopek.
1945
Establishing Vaccine Production Plant on the initiative of the director of the Medical Microbiology Institute at Jagiellonian University in Krakow Prof. Zdzislaw Przybylkiewicz, MD, PhD.

The page you are visiting makes use of cookies. Settings for these files can be changed in the options of browser used to browse the Internet. If you want to learn more about cookies files read the Privacy Policy.

 

If cookie settings are not changed, while browsing the site information will be automatically stored in the memory of your device. Do not show this message again: click here.